Over the past 50 years, per season pregnancy rate in Thoroughbred mares have risen from 70 to >90% and foaling rates from 55 to >80%. Some of the significant pharmacological treatments and diagnostic methods which have driven this marked improvement in breeding efficiency are reviewed. They include the application of artificial lighting to hasten the onset of ovulatory oestrous cyclicity in early Spring, rapid steroid hormone assays to aid in determining the stage and normality of the mare's cycle, prostaglandin analogues, synthetic progestagens and Gonadotrophin-releasing Hormone (GnRH) analogues to better control and manipulate her cycle to good effect, transrectal ultrasound scanning to monitor follicle growth, endometrial architecture and ovulation and to allow accurate, early pregnancy diagnosis thereby enabling successful ablation of one of twin conceptuses. Also, flexible videoendoscopy to monitor physiological and pathological changes in the uterine endometrium and rigid laparoscopy to apply prostaglandin to the oviducts to dislodge and clear suspected blockages of them to restore fertility. The outbreak of Contagious Equine Metritis in Newmarket in the spring of 1977 and the swabbing-related changes to mare and stallion management, plus the improved veterinary hygiene methods, which followed are also recounted. The past half century has witnessed many technical and therapeutic advances that have enhanced tremendously the diagnostic and treatment capabilities of studfarm veterinary surgeons. They, in turn, have improved greatly the efficiency of breeding Thoroughbreds and other types of horses.
Introduction
In the 1960s, fewer than 75% of Thoroughbred mares were covered and conceived one or more times during the out-of-phase "covering season" (15 February to 15 July) and only 50-55% produced a live foal the following year. Stallion book sizes ranged from 40 to 50 mares. The causes of this disappointing productivity included failure to show ovulatory oestrous periods during the covering season due to prolonged seasonal anoestrus, lactation-related anoestrus and the common occurrence of spontaneous prolonged dioestrus [1] . Endometritis, excessive caution in covering mares in which twin follicles could be palpated per rectum and prolonged eCGinduced anoestrus following removal of twin conceptuses first diagnosed 40-45 days after ovulation, also lowered pregnancy rates. Coupled with this "failure to be covered", high rates (8-10%) of early pregnancy loss between 14 and 42 days after ovulation went undiagnosed and abortion of twins was the highest cause of pregnancy loss in the second half of gestation [2] .
In non-Thoroughbred breeds, and with the notable, but at that time "hidden," exception of Russia and China [3, 4] , artificial insemination with fresh semen was rarely carried out, transport of cooled semen had not even been considered and the freezing of stallion semen was in its infancy. Embryo recovery and transfer had not yet been attempted in the mare and any other so-called modern breeding technologies were fanciful notions of the staff of biological research establishments.
Nowadays, by contrast, the per cycle pregnancy rate in Thoroughbred mares ranges from 63 to 69% depending upon mare age and type. End of season overall pregnancy rates exceed 90% and the live foal birth rate is around 85% [5] [6] [7] [8] [9] . Popular stallions now cover naturally in excess of 150 mares per season while maintaining high pregnancy rates [10, 11] , due largely to accurate veterinary prediction and hormonal control of the time of ovulation enabling only a single, optimally timed mating per oestrus.
In non-Thoroughbreds, a veritable revolution has taken place over the past two decades. The great majority of these mares are inseminated successfully with fresh, cooled or frozen semen and very few are nowadays covered naturally. Frozen semen is shipped around the world, thereby expanding the choice of stallions available to mare owners. Embryo transfer is used widely and successfully in many countries and large herds of recipient mares are maintained in Europe and the Americas. Furthermore, recent adaptations like Oocyte Transfer (OT), Gamete Intrafallopian Transfer (GIFT), Intracytoplasmic Sperm Injection (ICSI), Nuclear Transfer (NT; cloning) and the deep freezing of embryos, are being applied widely and successfully to Sporthorse and other nonThoroughbred breeds [12] [13] [14] [15] . Most dramatically perhaps, cloning is rapidly gaining acceptance and its use is increasing, especially in polo ponies in South America where, just before Christmas, 2016 no fewer than six clones of one champion filly played successfully in the final Grand Championship polo match near Buenos Aires [16] . The modern breeding technologies have indeed "come of age" and gained widescale and useful acceptance in the non-Thoroughbred horse breeding world. Significant advances in veterinary diagnostics and therapeutics during the past half century have enabled and driven the revolution in Thoroughbred breeding methods, applications and successes being achieved today.
Artificial lighting
The story of "lights for mares" started with John Burkhardt, a young veterinary graduate working with Sir John Hammond at the Animal Research Station, Cambridge soon after the war. Urged on by Fred Day, another Hammond assistant who was later to become a respected studfarm veterinary clinician in nearby Newmarket, Burkhardt housed a group of Pony mares in a barn over the winter and subjected them from the winter solstice to gradually increasing periods of artificial lighting in the evenings, timed to closely mimic the natural increase in day length that would occur 2 months later in Spring. Sure enough, the artificially lit mares began to show ovulatory oestrous cycles well ahead of their unlit controls [17] .
Day took the lighting method with him to Newmarket, along with rectal palpation of the ovaries and uterus to monitor follicular growth and diagnose pregnancy, while R.G. (Bob) Loy working in Kentucky picked up the lighting story and studied the effects of different lighting regimes on early season cyclicity in Thoroughbred mares. Importantly, he determined the minimum light intensities required to achieve the desired result and he made the important observation that suddenly increasing the duration of lighting to give a 16-h day length was as effective as slowly increasing the lit period to mimic the natural increase of advancing Spring [18] .
Work on artificial lighting reverted back to Europe in the 1980s when Eric Palmer and colleagues carried out an in-depth study of equine photoperiodicity. They demonstrated, importantly, that additional lighting is better applied to extend the evening rather than hasten the morning and that a 1-hour burst of light given 9.5-10.5 h after sunset (i.e. around 02.00 to 03.00 am) achieves the same result as leaving the lights on in the evening to give a 16 h day [19, 20] .
Nowadays, with the increasing commercial pressure to produce early foals for the yearling sales market, virtually all maiden and barren Thoroughbred mares in both the Northern and Southern hemispheres are maintained to good effect under a AE16 h per day light regime from around the time of the winter solstice. This results in the great majority of them being covered, and around 65% of them conceiving, by early March in the Northern hemisphere [5, 6, 9] . Getting so many of the maiden and barren mares covered early in the season eases the pressure on the foaling mares, stud staff and stallions alike so therefore has a significant influence on overall breeding efficiency. And most recently, the advent of (Fig 1) has also been shown to hasten early season oestrous cyclicity in barren and maiden mares [21] .
Hormone assays
One of the former causes of mares' failure to show ovulatory oestrous cycles during the breeding season was the common occurrence of "prolonged dioestrus" -spontaneous prolongation of the life of the cyclical corpus luteum (CL) in the absence of pregnancy [1] . The condition occurs at least once during the year in as many as 25% of mares (W.R. Allen, unpublished observations) when the CL persists in the ovary and continues to secrete progesterone for some 80-90 days. Up to the early 1970s, and prior to the advent of ultrasound scanning a decade later, prolonged dioestrus could not be diagnosed by rectal palpation since the persisting luteal tissue lay deep within the ovarian stroma (Fig 2a) . Treatment was limited to irrigating the mare's uterus with a large volume of saline (Fig 2b) , which appeared to be successful on some occasions simply because the treated mare's uterus became infected and the resulting acute endometritis stimulated the release of prostaglandin F 2 a (PGF 2 a) which, in turn, induced luteolysis. Or alternatively, the acidity of unbuffered saline similarly irritated the endometrium to stimulate prostaglandin release [22] .
Early assay methods for the steroid hormones, both oestrogen and progesterone, involved gas-liquid chromatography (GLC; [23] ) or radioimmunoassay (RIA; [24] ). Both techniques required expensive laboratory-based counting equipment and were unsuited to rapid clinical measurements and diagnoses. This situation changed with the development of sepharose gel separation and enzyme-linked immunoassay (ELISA) techniques which enabled veterinary practice laboratories to assay progesterone, and when required oestrogen, concentrations by the afternoon in mare serum samples collected by veterinary clinicians during their morning studfarm rounds [25] . This allowed the latter to accurately diagnose the persistence of active luteal tissue in mares' ovaries and treat them accordingly.
Nowadays, although benchtop ELISA kits allow rapid and accurate measurement of steroid and other hormone concentrations in the blood of mares and stallions, automated immunoanalysers are routinely used in many veterinary laboratories to provide even faster results.
Prostaglandin analogues
Another game changing moment in Thoroughbred breeding history occurred shortly after the advent of the sepharose gel separation assay for progesterone in peripheral blood when the author and his colleagues first infused a small dose of a newly developed Imperial Chemical Industries (ICI) analogue of prostaglandinF2a, known then only by the number ICI 79939, into the uterus of a pony mare on the 6th day after ovulation. Startlingly, she came strongly into oestrus 3 days later and ovulated 4 days after that, thereby shortening her oestrous cycle by some 8 days [26] . It was indeed a revelation and, very quickly, experimental mares were treated with varying doses of ICI 79939 at all stages of the oestrous cycle and by both the intramuscular and intrauterine routes of administration. These tests established that a much lower dose of prostaglandin was effective as a luteolytic agent in the mare than the cow, the CL was relatively insensitive to the actions of prostaglandin until 5 days after ovulation and intramuscular administration was as effective as intrauterine. At the same time, numerous noncycling Thoroughbred mares in Newmarket were treated with ICI 79939 with equally startling and pleasing results -mares that had not cycled for weeks showed strong oestrous behaviour and good follicle growth only 2-4 days after a single intramuscular injection of the drug (Fig 3; [27]).
Interestingly, and embarrassingly in hindsight, although upwards of 250 Thoroughbred mares in and around Newmarket were treated with ICI 79939 over a 3-month period in 1973, no adverse side effects of the drug were noticed. Yet when ICI personnel came to undertake a toxicity trial on the author's experimental herd the following winter, ICI 79939 induced severe, although short-lived, adverse responses some 10-15 min after administration. These included intense sweating, compulsive defaecation and stabbing colicky pains. The fact that none of these signs had been noticed on any of the studfarms co-operating in the trial stemmed from the common practise of turning mares out to the paddocks, and therefore out of sight, as soon as the veterinary surgeon had finished treating or handling them. The findings stimulated the ICI chemists to design and manufacture two further PGF 2 a analogues, fluprostenol and cloprostenol, for use in, respectively, horses and cattle.
Fluprostenol showed no adverse side effects whatever and it became the first prostaglandin marketed in the world for luteolytic purposes in domestic animals. The late Dr Mike Cooper, a highly experienced cattle reproduction veterinary practitioner, played a pivotal role in the development and testing of the prostaglandin F analogues [28, 29] .
Nowadays, PGF 2 a and its analogues are used widely and successfully throughout the horse breeding world, to treat prolonged dioestrus, shorten the dioestrous interval in mares that missed being inseminated or were infected in the previous oestrus, synchronise ovulation for embryo transfer or any other of the modern breeding technologies [28] [29] [30] , and stimulate prolonged uterine contractions to expel accumulated uterine fluids in mares with endometritis [31, 32] . In addition, PGF 2 a has been used to induce abortion [33, 34] and parturition [35, 36] , as a possible treatment to stimulate maternal behaviour and thereby overcome foal rejection [37] and, occasionally, to stimulate erection and ejaculation in shy or reluctant stallions [38] .
Progestagens
Hot on the heels of prostaglandin analogues came the development of allyl trenbolone (altrenogest), a potent, orally active, synthetic progestagen that could be administered easily per os on a daily basis to mares, nonpregnant and pregnant, to mimic closely the biological actions of endogenous progesterone and progestagens [39] . Further studies followed to assess the efficacy of oral altrenogest in clinical situations [40, 41] . In addition, the ability of altrenogest, but the failure of four other synthetic progestagens, namely medroxyprogesterone acetate, hydroxyprogesterone hexanoate, norgestomet and megesterol, to maintain early pregnancy in the absence of endogenous progesterone [42] helped to further secure the place of altrenogest. Since its original introduction onto the market, altrenogest has gained considerable use in pregnant mares, where it is frequently administered to mares with a history of any sort of pregnancy loss without any attempt to assay for progesterone/progestagen concentrations in their blood. This flies in the face of the seminal study by Irvine et al. [43] which showed convincingly that a lack of progesterone is not a significant cause of early pregnancy loss in the mare. It also disregards studies showing that the administration of altrenogest downregulates and suppresses endogenous progesterone production by the mare's own primary corpus luteum [44, 45] and pregnancy loss can occur in mares being administered altrenogest regardless of the elevated levels of the synthetic progestagen in their blood [44] . Latterly, long-acting progesterone or altrenogest, either compounded by pharmacies or commercially available in some countries, has been shown to be effective in suppressing oestrus [46, 47] and maintaining pregnancy [48, 49] , the latter use being commonplace in large embryo transfer centres in South America where recipient mares may be transitional or anoestrus.
Outside the studfarm environment, oral altrenogest is administered widely to mares to prevent them from showing oestrous behaviour to the detriment of their expected performance. And although it has been suggested, anecdotally, that it might have an anabolic effect Hodgson et al. [50] found no effect on dominance hierarchies, body-mass or condition score in sedentary mares following prolonged oral administration. Indeed, the use of altrenogest is currently permitted by the Federation Equestrienne Internationale (FEI) for mares with oestrus-related behavioural problems providing its use is declared. Furthermore, since testosterone is synthesised and secreted by the Leydig cells of the testes in response to luteinising hormone (LH), altrenogest, by causing suppression of LH and, hence testosterone, production has also been used to suppress aggressive and sexual behaviour in colts and stallions (reviewed in [51] ).
Contagious equine metritis (CEM)
In April, 1977 mares covered by stallions standing at The National Stud, Newmarket "came up dirty" 6-8 days after an ovulatory mating and they began to excrete copious amounts of pus from the vulva which became encrusted on the underside of the tail and perineum (Fig 4a) . Conventional culture of the pus yielded no bacterial growth yet increasing numbers of mares on the stud which had been covered by different stallions showed the same clinical signs of acute, purulent endometritis with negative bacterial culture. And quite soon, mares on other studs around Newmarket began experiencing acute endometritis and cervicitis (Fig 4b) . Covering ceased at many studfarms in the area while an urgent bacteriological and epidemiological study was carried out at Newmarket's Animal Health Trust. Interestingly, this scenario of a venereal disease halting covering in Newmarket had been presaged 7 years earlier by the late Peter Burrell CBE, Director of the British National Stud. It stimulated him to find the funds to establish the author's Equine Fertility Unit, initially at the internationally renowned and highly productive Animal Research Station in Cambridge from 1970 to 1986, and then at purpose-built facilities at Mertoun Paddocks in Newmarket until 2007. The fear of a venereal outbreak persuaded Burrell to create a 2-year Postdoctoral Fellowship at The Animal Research Station with the remit to develop the freezing of stallion semen. This with a view to storing frozen semen from all the major Thoroughbred stallions for use with artificial insemination (AI) in the event of the feared venereal outbreak. Sadly, the Stewards of the Jockey Club vetoed the project outright and the well-reasoned store of frozen semen did not exist when the CEM outbreak occurred only 7 years later.
All manner of "experts" were drafted onto the job during the spring and summer of 1977 when the local veterinary clinicians struggled to contain the situation, all the while in the absence of any positive bacterial growth from the numerous swabs recovered from the mares and the penis and sheath of the symptomless stallions. The late Donald Simpson MRCVS, veterinary clinician attending The National Stud, worked tirelessly to find a solution which came, when Jim Atherton, bacteriologist at The Animal Health Trust, elicited the advice and help of a colleague, Dr Eddie Taylor, chief bacteriologist of a research group working on human infectious diseases at Addenbrooke's Hospital in Cambridge. He cultured some swabs from infected mares microaerophyllically (i.e. in an atmosphere containing 5% CO 2 ) and, 5 days later, small grey colonies appeared on the culture plate (Fig 4c) of a bacterium that turned out not to have been described previously [52] [53] [54] . It was appropriately named Taylorella equigenitalis and the disease itself was termed Contagious Equine Metritis (CEM). The organism proved sensitive to penicillin, the heavy administration of which soon cleared up the problem so that covering could restart, albeit rather late in the season.
Meanwhile Donald Simpson had been labouring to discover how and why the disease spread so quickly through the mare population, how multiple stallions became involved yet showed no clinical signs themselves, and what part veterinary surgeons had played in the spread. Very importantly, Simpson demonstrated that the bacterium could reside asymptomatically in the ventral fossa and the two small blind ending ducts on either side of the mare's clitoris from where it could easily be taken forward to the cervix and initiate the endometritis, both by the stallion's penis during mating and the veterinary clinician's arm when performing vaginal and/or rectal examinations of the mare. It also resided asymptomatically on the shaft and within the prepuce and urethral fossa of the stallion's penis [55, 56] . A number of important and practical outcomes arose from the 1977 epidemic in Newmarket. Principal among these was the establishment by The Horserace Betting Levy Board of a Code of Practice for swabbing mares and stallions and for general disease control within and between studfarms. Nowadays, this continues to serve as the bible of good veterinary preventative medicine associated with horse breeding [57] and is the basis of the EquiBioSafe app (https://itunes.apple.com/gb/app/ equibiosafe-hblb-and-ntf-codes-of-practice/id1131137694?mt=8; https://pla y.google.com/store/apps/details?id=com.veterinaryadvances.android.e quibiosafe). A second benefit has been wide scale and mandatory swabbing of mares and stallions for CEM and other venereal pathogens at the start of the covering season, together with routine intrauterine swabbing of Thoroughbred mares early in oestrus before they are covered. The introduction of real-time polymerase chain reaction (PCR) assays to diagnose CEM-positive mares and stallions now gives results in less than 6 h vs. a conclusive negative culture result of not less than 7 days [58] . And a third laudable outcome has been a marked improvement in general veterinary hygiene on stud farms resulting in a much lower incidence of venereal infections in mares and stallions and a more rapid diagnosis and effective treatment of nonvenereal endometritis in individual mares.
Gonadotrophin-releasing hormone analogues
Human Chorionic Gonadotrophin (hCG) had been used widely since the 1940s to hasten maturation of the oestrous follicle and oocyte within it and then to induce ovulation and release of the oocyte 36-39 h after administration [59, 60] . It is relatively cheap and very effective but, as a large glycoprotein molecule of human origin, it is antigenic to the mare and therefore has the potential to induce the development of anti-hCG antibodies in mares treated in repeated oestrous cycles. These then crossreact with the mare's endogenous LH to neutralise its biological activity and thereby induce long periods of ovulation failure and resulting infertility in affected animals [61, 62] .
Gonadotrophin-releasing Hormone (GnRH) is the small peptide released in spike-like bursts from the hypothalamus which, after reaching the adjacent pituitary gland via the hypothalamic-pituitary portal blood system, stimulates release of both major gonadotrophins, Follicle Stimulating Hormone (FSH) and Luteinising Hormone (LH), into the peripheral circulation to stimulate gonadal activity in the male or female. The advent in the 1990s of a series of biologically active synthetic analogues of GnRH was a welcome practical alternative to inducing ovulation in mares without the risk of deleterious antibody formation associated with the repeated use of hCG [63] [64] [65] . The GnRH analogue, deslorelin acetate, when incorporated into a slow-release subcutaneous implant, proved highly efficacious in hastening and inducing ovulation some 40-42 h after administration [66] [67] [68] . However, it has the potential disadvantage of downregulating endogenous GnRH release from the hypothalamus if the implant is left in situ too long and/or is used in successive cycles, resulting in an extended inter-ovulatory period [69] , although this can be prevented by removing the implant once ovulation has occurred [70] . A number of injectable GnRH analogues have now been produced commercially [71, 72] and are used widely and to good effect throughout the horse breeding world to induce ovulation.
Ultrasonography
A real "game changer" in equine reproduction research and practical stud management occurred in France in 1980 when Dr Eric Palmer borrowed his Paris obstetrician father's Aloka real-time ultrasound scanner and bravely inserted the bulky, 3.5 MHz linear array probe into the rectum of one of his experimental mares (Fig 5a) . And there, for the first time, he could see the cross-sectional image of the ovaries and uterus, with the large, fluid-filled ovarian follicles in the former and the spherical, fluid-filled conceptus moving freely through the uterine lumen of the latter in early pregnancy [73] . Although by today's standards, the green images were distinctly blurry and lacking in detail (Fig 6a) , they nevertheless highlighted the structures that were of practical significance to the studfarm veterinary clinician and, at a stroke, multiplied greatly his or her diagnostic and prognostic capabilities. It was a real revelation, made all the more possible and applicable to the mare by virtue of her simple and straight-horned uterus situated immediately below her easily penetrated rectum, her large ovaries and relatively enormous fluid-filled follicles, and the existence of the equine blastocyst capsule [74] to keep the young conceptus spherical, unattached and mobile within the uterine lumen until as late as 17 days of gestation.
Palmer kindly demonstrated his scanner to the author who then convinced the very benevolent American heiress, Connie Mellon, second wife of Peter Burrell, instigator of The Equine Fertility Unit, of the need to purchase one for testing on Thoroughbred mares in Newmarket. It duly arrived and was mounted on a specially made collapsible trolley with semiinflated pneumatic tyres (Fig 5b) to ease its daily transport between Cambridge and Newmarket and to wheel it over the rough ground when moving between stables to examine mares -stocks were a rarity in Newmarket in those days. A clinical trial was carried out in which over 300 mares at all stages of the oestrous cycle and first 60 days of gestation were scanned on one or more occasions. The results were a revelation [75, 76] and, even with the fuzzy and imprecise image obtained, it quickly became apparent that the ultrasound scanner would prove invaluable to monitor growth of the dominant follicle during oestrus to the point of ovulation and afterwards during development of the corpus haemorrhagicum and luteum, that it could detect accurately the presence of the spherical, fluid-filled conceptus in the uterus from as early as Day 12 after ovulation and it could differentiate twins from
Videoendoscopic images of a) a dioestrous cervix; b) the prominent bifurcation between the uterine horns in a healthy uterus; c) a healthy endometrium when looking up a uterine horn; d) the uterotubal papilla at the tip of a uterine horn; e) a thinning and fibrosed endometrium looking up a uterine horn in an aged, multiparous mare; f) a small endometrial cyst protruding from the wall of a uterine horn.
around Day 14 to allow the veterinary clinician to separate the two unattached conceptuses and destroy one by "pinching " it through the wall of the rectum. But perhaps most important of all from the stud management point of view, it could accurately determine that a mare was definitely not pregnant as early as 14 days after ovulation, thereby enabling the clinician to confidently administer prostaglandin to induce luteolysis and bring her back into oestrus for remating. Thus, almost at a stroke, the scanner eliminated the two scourges of Thoroughbred breeding -the need to wait until as late as 42 days after mating to know for certain that any particular mare was pregnant, had failed to conceive or had undergone early embryonic death, and late gestation abortion of undiagnosed twins.
The ultrasound manufacturers responded quickly to this new application by producing smaller and more portable machines that could run off batteries, have smaller probes to facilitate transrectal passage and have increased range and power of the ultrasound beam, from 3.5 to as high, nowadays, as 12 MHz, thereby reducing or increasing the depth of penetration of the beam and increasing dramatically the clarity and detail of the image produced on the screen.
In addition to B-mode ultrasonography, many scanners now have colour or spectral Doppler capabilities allowing the assessment of blood flow in the reproductive tract [77] . These can measure the absence, presence, direction and quantify blood flow to assess development and function of the corpus luteum, predict ovulation, indicate the presence of the fetal [78] [79] [80] [81] [82] [83] [84] .
It is unarguably true that the judicious daily use of modern ultrasound scanners on the studfarm has been the single factor most responsible for the dramatic increase in singleton ongoing pregnancy and live birth foaling rates in Thoroughbred breeding worldwide over the past 30 years. It has also helped enormously to revolutionise breeding practices in Sporthorses, including artificial insemination (AI) with frozen semen, straightforward embryo transfer (ET) and the other modern breeding technologies. The introduction of ultrasound scanning to horse breeding via Eric Palmer's liberated human scanner 37 years ago was indeed transformational.
Videoendoscopy and laparoscopy
The rapid advances in endoscopy technology over the past 20 years, both rigid and flexible, have benefited equine reproduction in a number of ways. First, the flexible endoscope, when passed through the tight dioestrous cervix (to help keep insufflated air in the uterus) allows the operator to wander round the uterine lumen viewing and assessing the general layout and overall health of the endometrium (Fig 7) before moving to the tip of each uterine horn to examine the presence and normality of the uterotubal papillae (Fig 7d) . Endometrial cysts (Figs 7f and 8a-c) and fibrous adhesions resulting from injudicious infusion of irritant solutions into the uterus can be assessed (Fig 8f) and sightdirected endometrial biopsies recovered using either the flexible biopsy forceps passed down the working channel of the scope, or the much larger, rigid biopsy forceps passed through the cervix alongside the endoscope and, under visual control, manipulated further to the area of interest [85, 86] .
The subsequent development of flexible NdYAG laser technology added an extra dimension to videoendoscopy by allowing minor surgical repairs and ablations to be performed in utero, including the destruction and virtual ablation of large, fluid-filled endometrial cysts sited where they might impede free movement of the young embryo throughout the uterine lumen between Days 10 and 16 after ovulation (Figs 8a-c) , or ablate intrauterine fibrous adhesions (Fig 8f; [87] ). As with many other reproductive procedures in the mare, her straight and easily penetrated cervix combined with the straight body and horns of the uterus make the whole process of uterine videoendoscopy and laser surgery very simple and fruitful in diagnostic and reparative terms. This is borne out by the ready ability to pass the endoscope up the uterine horn ipsilateral to the dominant follicle in an oestrous mare to achieve high conception rates when depositing very low doses of fresh or frozen/thawed spermatozoa (e.g. 1-5 million) suspended in only 200 uL of TALP medium directly onto the external surface of the uterotubal papilla (Fig 7d; [88] ).
Passage of the rigid laparoscope through the surgically prepared and locally anaesthetised flank of the mare (Fig 9a) has also seen increasing use in equine stud medicine in recent years, both to remove normal or diseased (e.g. granulosa cell tumorous) ovaries from mares, or abdominally retained cryptorchid testes from colts [89] . A more recent application has been to use laparoscopy to apply a prostaglandin E 2 gel preparation, designed to soften and dilate the cervix in pregnant women to facilitate labour, to the whole length of the equine oviduct (Fig 9b; [90] ) to presumptively unblock the oviducts of infertile mares. Application of the gel to the oviduct induces relaxation of the circular and contraction of the longitudinal smooth muscle fibres in the wall of the oviduct, thereby mimicking the PGE 2 normally released by the equine embryo to "drive itself" down the oviduct [91, 92] and through the very tight uterotubal junction to enter the uterus on Day 6-6.5 after ovulation [93] . The supraphysiological dose of the drug is believed to clear accumulations of oviducal masses (Fig 9c) and allows the fertilised oocyte to pass through the oviduct. The careful selection of mares for treatment with oviducally applied PGE 2 gel, based entirely on the veterinary exclusion of other possible causes of their persisting infertility, has given very impressive results, especially in mares treated 4 or 5 days after a previous mating or insemination and which then exhibit a normal 14 days pregnancy when scanned 10 days later (H. Neal et al., unpublished data).
Conclusions
The senior author is sincerely grateful for his "lottery of birth" which gave him the chance to live and research equine reproductive physiology during the past 50 years, a time of great technological advancement and change, which has benefitted the Thoroughbred and other horse breeds enormously. Nowadays, we understand and appreciate much better the physiological and hormonal mechanisms involved in seasonality, oestrous cyclicity, follicle growth and ovulation, conception, embryonic growth and movement, implantation, placentation, birth and lactation in the mare and seasonality, spermatogenesis, libido and ejaculation in the stallion. And we can intervene and manipulate these processes, usually to good practical effect, and certainly to the marked improvement of pregnancy rate and live foal birth rate figures.
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